13 insiders reported 154 Form 4 transactions for JOHNSON & JOHNSON (JNJ) over the past 18 months (most recent 2026-08-18). Recent activity: Taubert Jennifer L (EVP, WWC. Innovative Medicine) Buy 15,000 shares, Taubert Jennifer L (EVP, WWC. Innovative Medicine) Sell 15,000 shares, Duato Joaquin (CEO and Chairman of the Board) Sell 102,315 shares, Duato Joaquin (CEO and Chairman of the Board) Sell 20,976 shares, Duato Joaquin (CEO and Chairman of the Board) Buy 123,291 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 15,000 | $1.7M |
| 2026-08-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 15,000 | $4.0M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | Sell | 102,315 | $26.7M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | Sell | 20,976 | $5.5M |
| 2026-08-14 | Duato Joaquin | CEO and Chairman of the Board | Buy | 123,291 | $14.3M |
| 2026-08-07 | Duato Joaquin | CEO and Chairman of the Board | Sell | 41,957 | $10.8M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | Buy | 9,344 | $1.2M |
| 2026-08-07 | Duato Joaquin | CEO and Chairman of the Board | Sell | 6,523 | $1.7M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | Sell | 9,344 | $2.4M |
| 2026-08-07 | Forminard Elizabeth | EVP, Chief Legal Officer | Sell | 6,574 | $1.7M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | Buy | 11,129 | $1.4M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | Buy | 11,925 | $1.6M |
| 2026-07-21 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 23,054 | $5.8M |
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Buy | 10,000 | $1.2M |
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | 10,000 | $2.4M |
| 2026-05-04 | REED JOHN C | EVP, Innovative Medicine, R&D | Buy | 25,255 | $0 |
| 2026-05-04 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 11,002 | $2.5M |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | Buy | 4,075 | $471,355 |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | Sell | 4,075 | $1.0M |
| 2026-02-23 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 1,322 | $324,763 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 1,594 | $0 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 1,302 | $0 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 409 | $100,021 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 27,412 | $0 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 13,547 | $3.3M |
Source: SEC Form 4 filings · as of 2026-08-18